Fredrik Schjesvold on OCEAN phase 3

FromThe Lancet Haematology in conversation with

Start listening View podcast show

Fredrik Schjesvold on OCEAN phase 3

FromThe Lancet Haematology in conversation with

ratings:

Length:

12 minutes

Released:

Jan 31, 2022

Format:

Podcast episode

Description

Dr Fredrik Schjesvold discusses the results of the OCEAN phase 3 trial testing melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide. Read the full article:Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN)

Released:

Jan 31, 2022

Format:

Podcast episode

Titles in the series (43)

Lan-Lan Smith, Editor-in-Chief of The Lancet Haematology, and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.

Skip carousel

The Lancet Haematology: December 1, 2014 by The Lancet Haematology in conversation with
11 min listen
The Lancet Haematology: January 7, 2015 by The Lancet Haematology in conversation with
10 min listen
1 million stem cells: The Lancet Haematology: February 27, 2015 by The Lancet Haematology in conversation with
13 min listen
Deep-vein thrombosis: The Lancet Haematology, October 29, 2015 by The Lancet Haematology in conversation with
8 min listen
INWORKS: The Lancet Haematology: June 29, 2015 by The Lancet Haematology in conversation with
7 min listen
Warfarin: The Lancet Haematology: May 26, 2015 by The Lancet Haematology in conversation with
12 min listen
Trauma-induced coagulopathy: The Lancet Haematology: June issue by The Lancet Haematology in conversation with
9 min listen
Castleman disease: The Lancet Haematology: March 17, 2016 by The Lancet Haematology in conversation with
17 min listen
Atrial fibrillation and NOACs: The Lancet Haematology: April 2, 2015 by The Lancet Haematology in conversation with
9 min listen
Financial toxicity: The Lancet Haematology: September 17, 2015 by The Lancet Haematology in conversation with
6 min listen
Idiopathic thrombocytopenic purpura: The Lancet Haematology: July 29, 2015 by The Lancet Haematology in conversation with
6 min listen
Childhood leukaemia survival (CONCORD-2): The Lancet Haematology: April 11, 2017 by The Lancet Haematology in conversation with
6 min listen
Economic burden of blood disorders in Europe: The Lancet Haematology: July 21, 2016 by The Lancet Haematology in conversation with
10 min listen
Imatinib for paediatric leukaemia by The Lancet Haematology in conversation with
9 min listen
Adverse events in haematological malignancies by The Lancet Haematology in conversation with
13 min listen
Superficial-vein thrombosis: The Lancet Haematology: February 15 2017 by The Lancet Haematology in conversation with
10 min listen
Nada Hamad on inclusion and diversity in haematology by The Lancet Haematology in conversation with
30 min listen
Eugenia Trigoso Arjona (in English) on nursing and haematological care by The Lancet Haematology in conversation with
29 min listen
Dr Judith Boer on lymphoblastic leukaemia in children by The Lancet Haematology in conversation with
10 min listen
EPO blood doping and cycling: The Lancet Haematology: June 29, 2017 by The Lancet Haematology in conversation with
9 min listen
Predicting the risk of adenoviraemia by The Lancet Haematology in conversation with
5 min listen
Raul Cordoba on haematological malignancies in older people by The Lancet Haematology in conversation with
16 min listen
Eugenia Trigoso Arjona (in Spanish) on nursing and haematological care by The Lancet Haematology in conversation with
29 min listen
Oreofe Odejide and Thomas Kuczmarski on mental health and lymphoma by The Lancet Haematology in conversation with
17 min listen
Zuguo Mei and Gary Brittenham on iron deficiency by The Lancet Haematology in conversation with
9 min listen
Fredrik Schjesvold on OCEAN phase 3 by The Lancet Haematology in conversation with
12 min listen
Jacob D Soumerai and Andrew D Zelenetz on the BOVen regimen for previously untreated patients with chronic lymphocytic leukaemia by The Lancet Haematology in conversation with
12 min listen
Xiao-Jun Huang on cellular therapy in China by The Lancet Haematology in conversation with
28 min listen
Amy DeZern on the link between myelodysplastic syndrome and autoimmune disorders by The Lancet Haematology in conversation with
13 min listen
Nicholas Crombie and Gavin Perkins on resuscitation with blood products compared with saline by The Lancet Haematology in conversation with
15 min listen

More Episodes from The Lancet Haematology in conversation with

Skip carousel

Sabine Braat and Katherine Fielding on haemoglobin thresholds to define anaemia by The Lancet Haematology in conversation with
18 min listen
Elisabeth Schorb on the MARTA phase 2 trial by The Lancet Haematology in conversation with
9 min listen
Stephan Ehl on paediatric autoimmune lymphoproliferative immunodeficiencies by The Lancet Haematology in conversation with
13 min listen
Dr Susan O'Brien on the PREVAPIX-ALL trial by The Lancet Haematology in conversation with
14 min listen
Enrico Lopriore on haemolytic disease of the fetus and newborn by The Lancet Haematology in conversation with
13 min listen
Meletios Dimopoulos on relapsed and refractory multiple myeloma by The Lancet Haematology in conversation with
11 min listen
$Meletios Dimopoulos on relapsed and refractory multiple myeloma$
Eric Ohuma on haemoglobin concentrations and neonatal outcomes by The Lancet Haematology in conversation with
16 min listen
Margaret Ragni on tranexamic acid to treat heavy menstrual bleeding by The Lancet Haematology in conversation with
13 min listen
Oreofe Odejide and Thomas Kuczmarski on mental health and lymphoma by The Lancet Haematology in conversation with
17 min listen
Alok Srivastava on fitusiran for patients with haemophilia A and B by The Lancet Haematology in conversation with
19 min listen
Emmanuela E Ambrose on stroke prevention in children with sickle cell disease by The Lancet Haematology in conversation with
12 min listen
Sumit Gupta on racial and ethnic disparities in leukaemia survival outcomes by The Lancet Haematology in conversation with
22 min listen
Xiao-Jun Huang on cellular therapy in China by The Lancet Haematology in conversation with
28 min listen
Glenn Pierce on haemophilia care in LMICs by The Lancet Haematology in conversation with
35 min listen
Amy DeZern on the link between myelodysplastic syndrome and autoimmune disorders by The Lancet Haematology in conversation with
13 min listen
Nicholas Crombie and Gavin Perkins on resuscitation with blood products compared with saline by The Lancet Haematology in conversation with
15 min listen
Jacob D Soumerai and Andrew D Zelenetz on the BOVen regimen for previously untreated patients with chronic lymphocytic leukaemia by The Lancet Haematology in conversation with
12 min listen
Raul Cordoba on haematological malignancies in older people by The Lancet Haematology in conversation with
16 min listen
Obiageli Nnodu and Dennis Chao on child mortality from sickle cell disease in Nigeria by The Lancet Haematology in conversation with
9 min listen
Zuguo Mei and Gary Brittenham on iron deficiency by The Lancet Haematology in conversation with
9 min listen
Eugenia Trigoso Arjona (in Spanish) on nursing and haematological care by The Lancet Haematology in conversation with
29 min listen
Eugenia Trigoso Arjona (in English) on nursing and haematological care by The Lancet Haematology in conversation with
29 min listen
Nada Hamad on inclusion and diversity in haematology by The Lancet Haematology in conversation with
30 min listen
Dr Judith Boer on lymphoblastic leukaemia in children by The Lancet Haematology in conversation with
10 min listen
Imatinib for paediatric leukaemia by The Lancet Haematology in conversation with
9 min listen
Predicting the risk of adenoviraemia by The Lancet Haematology in conversation with
5 min listen
Adverse events in haematological malignancies by The Lancet Haematology in conversation with
13 min listen
EPO blood doping and cycling: The Lancet Haematology: June 29, 2017 by The Lancet Haematology in conversation with
9 min listen
Trauma-induced coagulopathy: The Lancet Haematology: June issue by The Lancet Haematology in conversation with
9 min listen
Childhood leukaemia survival (CONCORD-2): The Lancet Haematology: April 11, 2017 by The Lancet Haematology in conversation with
6 min listen

Related podcast episodes

Skip carousel

Removing the Confusion Surrounding Some Commonly Used Therapies by Derms and Conditions
23 min listen
Keeping up with the Chemos Series: Follow up Monitoring Between Cycles (Part 3) by SGO on the GO
11 min listen
"CDK4/6 Inhibitor Plus Hormonal Therapy Should Be First Treatment for Metastatic Hormone-Receptor-Positive, HER2-Negative Breast Cancer" ESMO 2019 Coverage: Dr. Dennis Slamon discusses overall survival results from the MONALEESA-3 study. by Breastcancer.org Podcast
9 min listen
Episode 26: EPOCH Trial results suggest promising treatment for metastatic colorectal cancer patients by The Kinked Wire
22 min listen
Recent Approvals: Duvelisib for Adult Patients with Relapsed or Refractory CLL or SLL: Recent Approvals: Duvelisib for Adult Patients with Relapsed or Refractory CLL or SLL by ASCO Education
5 min listen
$Recent Approvals: Duvelisib for Adult Patients with Relapsed or Refractory CLL or SLL: Recent Approvals: Duvelisib for Adult Patients with Relapsed or Refractory CLL or SLL$
Ep. 68 In-Office Procedures for Nasal Valve Obstruction with Dr. Mary Ashmead: In this episode of BackTable ENT, Dr. Ashley Agan and Dr. Gopi Shah speak with Dr. Mary Ashmead, a Dallas/Fort Worth based rhinologist (Texas Ear, Nose, & Throat Specialists) about in-office procedures for nasal valve obstruction. by BackTable ENT
73 min listen
Circulation August 29, 2023 Issue: Circulation Weekly: Your Weekly Summary & Backstage Pass To The Journal by Circulation on the Run
26 min listen
"Going to the PROM with Dr. Caroline Friedman": Dr. Fox welcomes Dr. Caroline Friedman back to th… by Healthful Woman Podcast
24 min listen
Untangling the Questions and Challenges in Patients with Hair Loss: Part 2 by Derms and Conditions
26 min listen
Lit Update: Pulmonary Embolism Diagnosis Update: An Emergency Medicine Podcast by FOAMcast - An Emergency Medicine Podcast
8 min listen
Joseph Mikhael, MD, MEd, FRCPC / Paul G. Richardson, MD - Window of Opportunity in Relapsed/Refractory Multiple Myeloma: Is There an Earlier Role for Cereblon (CRBN) E3 Ligase Modulators to Improve Patient Outcomes?: Please visit answersincme.com/EUY860 to participate, download slides and supporting materials, complete the post test, and obtain credit. by CME in Minutes: Education in Oncology & Hematology
16 min listen
$Joseph Mikhael, MD, MEd, FRCPC / Paul G. Richardson, MD - Window of Opportunity in Relapsed/Refractory Multiple Myeloma: Is There an Earlier Role for Cereblon (CRBN) E3 Ligase Modulators to Improve Patient Outcomes?: Please visit answersincme.com/EUY860 to participate, download slides and supporting materials, complete the post test, and obtain credit.$
Key Decisions in HIV Care: Data on Long-Acting Injectable PrEP: Listen as Jason Schafer, PharmD, MPH, shares the latest data to support long-acting PrEP, including efficacy and safety data from the major clinical trials that led to the approval of cabotegravir for PrEP. by CCO Infectious Disease Podcast
18 min listen
Podcast 526: Desmopressin for Intracranial Hemorrhage: Contributor: Charleen Melton, PharmD Educational Pearls: Desmopressin (DDAVP) is an analogue of anti-diuretic hormone (ADH) that has been used for the treatment of intracranial hemorrhage. It works by increasing the release of Von Willebrand factor,... by Emergency Medical Minute
4 min listen
Circulation April 10, 2018 Issue by Circulation on the Run
25 min listen
Where are we now with CBD and other questions facing dermatology? Perspectives from Adam Friedman, MD by Derms and Conditions
23 min listen
Circulation September 19, 2017 Issue: Circulation Weekly: Your Weekly Summary & Backstage Pass To The Journal by Circulation on the Run
23 min listen
Podcast # 488: Dalbavancin: Contributor: Nick Hatch, MD Educational Pearls: Dalbavancin (Dalvance®) is an antibiotic that can be used for skin and soft tissue infections, providing MRSA coverage It cannot be used in other infections or sepsis Dalbavancin may be appealing as a... by Emergency Medical Minute
4 min listen
Ep. 92 The Evolving Management of Stage II Seminoma with Dr. Sia Daneshman: In this episode of BackTable, Dr. Bagrodia interviews Dr. Sia Daneshmand, chief of urologic oncology at the University of Southern California, about the research trials and treatment of stage II seminomas. by BackTable Urology
44 min listen
Emerging Scientific Data and Unique Clinical Scenarios in People With NTM Lung Disease: Listen to Shannon Kasperbauer, MD, discuss emerging scientific data and unique clinical scenarios in people with nontuberculous mycobacterial (NTM) lung disease, specifically focusing on Mycobacteroides abscessus. by CCO Infectious Disease Podcast
21 min listen
ACCEL Lite: ESC Late Breaker: MASTER DAPT: Dual Antiplatelet Therapy After Coronary Stenting in High Bleeding Risk Patients by ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
12 min listen
Ep. 233 Desmoid Tumors: IR's Role in Diagnosis and Management with Dr. Jack Jennings: In this episode, host Dr. Jacob Fleming interviews Dr. Jack Jennings about cryoablation, multidisciplinary care, and practice building for the treatment of desmoid tumors. by BackTable Vascular & Interventional
66 min listen
You've Got One Shot To Get It Right with April Armstrong, MD, MPH by Derms and Conditions
22 min listen
Final Thoughts from 2023: Highlights from Podcasts Past… by Derms and Conditions
31 min listen
Ep. 63 Evaluation and Management of Nasal Valve Collapse with Dr. Moustafa Mourad: In this episode of BackTable ENT, Dr. Agan and Dr. Shah discuss nasal valve collapse and repair with Dr. Moustafa Mourad, a New York City-based facial plastic and reconstructive surgeon. by BackTable ENT
53 min listen
How I treat MDS: Dr. Shannon McCurdy talks prognostic scoring, ESAs, HMAs, transplant, and more: Treatment strategies for myelodysplastic syndromes (MDS) vary widely depending upon patients’ prognosis. In this episode, Shannon R. McCurdy, MD, of the University of Pennsylvania, Philadelphia, joined host David H. Henry, MD, to discuss how she... by Blood & Cancer
32 min listen
PSMA trumps conventional imaging - proPSMA discussion by GU Cast
34 min listen
Ep. 169 Navigating Type I Laryngeal Clefts in Children with Dr. Hamdy El-Hakim: In this episode, Dr. Hamdy El-Hakim, pediatric airway surgeon and Associate Professor at the University of Alberta, joins host Dr. Gopi Shah to review laryngeal clefts in children. by BackTable ENT
74 min listen
Part 3: Keeping up with the Chemos Series: Follow up Monitoring Between Cycles (Trametinib) by SGO on the GO
16 min listen
059 - The five oncology drugs every pharmacist should know about: In this episode, we discuss with Dr. Megan Hartranft the five oncology drugs that every pharmacist should know about, which is a great review for P4 students who are currently preparing for the NAPLEX. We cover cyclophosphamide, cisplatin,... by HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast
38 min listen
Circulation January 24, 2023 Issue: Circulation Weekly: Your Weekly Summary & Backstage Pass To The Journal by Circulation on the Run
30 min listen

Discover this podcast and so much more

Fredrik Schjesvold on OCEAN phase 3

Fredrik Schjesvold on OCEAN phase 3

Description

Titles in the series (43)

More Episodes from The Lancet Haematology in conversation with

Related podcast episodes